| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 06:50:16 UTC |
|---|
| Update Date | 2022-11-30 19:26:27 UTC |
|---|
| HMDB ID | HMDB0116051 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | CDP-DG(18:2(9Z,11Z)/a-25:0) |
|---|
| Description | CDP-DG(18:2(9Z,11Z)/a-25:0) is a cytidine diphosphate diacylglycerol or CDP-diacylglycerol (CDP-DG). CDP-diacylglycerol is an important branchpoint intermediate in eukaryotic phospholipid biosynthesis and could be a key regulatory molecule in phospholipid metabolism. It is a glycerophospholipid in which a cytidine diphosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. CDP-DG(18:2(9Z,11Z)/a-25:0), in particular, consists of one chain of (9Z,11Z)-octadecadienoic acid at the C-1 position and one chain of anteisopentacosanoic acid at the C-2 position. Cytidine diphosphate diacylglycerols are rarely noticed in analyses of lipid compositions of tissues, as they are present is such small amounts (perhaps only 0.05% or so of the total phospholipids). |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCC\C=C/C=C\CCCCCC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC InChI=1S/C55H99N3O15P2/c1-4-6-7-8-9-10-11-12-17-21-24-27-30-33-36-39-50(59)68-43-47(71-51(60)40-37-34-31-28-25-22-19-16-14-13-15-18-20-23-26-29-32-35-38-46(3)5-2)44-69-74(64,65)73-75(66,67)70-45-48-52(61)53(62)54(72-48)58-42-41-49(56)57-55(58)63/h10-12,17,41-42,46-48,52-54,61-62H,4-9,13-16,18-40,43-45H2,1-3H3,(H,64,65)(H,66,67)(H2,56,57,63)/b11-10-,17-12-/t46?,47-,48-,52+,53?,54-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-(9Z,11Z)-Octadecadienoyl-2-anteisopentacosanoyl-sn-glycero-3-CDP | HMDB | | 1-(9Z,11Z)-Octadecadienoyl-2-anteisopentacosanoyl-sn-glycero-3-cytidine-5'-diphosphate | HMDB | | CDP-DG(18:2/A-25:0) | HMDB | | CDP-DG(18:2N7/A-25:0) | HMDB | | CDP-DG(18:2W7/A-25:0) | HMDB | | CDP-DG(43:2) | HMDB | | CDP-Diacylglycerol(18:2(9Z,11Z)/A-25:0) | HMDB | | CDP-Diacylglycerol(18:2/A-25:0) | HMDB | | CDP-Diacylglycerol(18:2N7/A-25:0) | HMDB | | CDP-Diacylglycerol(18:2W7/A-25:0) | HMDB | | CDP-Diacylglycerol(43:2) | HMDB | | {[(2R,3R,5R)-3,4-dihydroxy-5-(2-hydroxy-4-imino-1,4-dihydropyrimidin-1-yl)oxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(22-methyltetracosanoyl)oxy]-3-[(11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinate | HMDB | | CDP-DG(18:2(9Z,11Z)/a-25:0) | SMPDB |
|
|---|
| Chemical Formula | C55H99N3O15P2 |
|---|
| Average Molecular Weight | 1104.351 |
|---|
| Monoisotopic Molecular Weight | 1103.655143496 |
|---|
| IUPAC Name | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(2R)-2-[(22-methyltetracosanoyl)oxy]-3-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy]phosphoryl}oxy)phosphinic acid |
|---|
| Traditional Name | [(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy([hydroxy((2R)-2-[(22-methyltetracosanoyl)oxy]-3-[(9Z,11Z)-octadeca-9,11-dienoyloxy]propoxy)phosphoryl]oxy)phosphinic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCC\C=C/C=C\CCCCCC)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H](C(O)[C@H]1O)N1C=CC(N)=NC1=O)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC |
|---|
| InChI Identifier | InChI=1S/C55H99N3O15P2/c1-4-6-7-8-9-10-11-12-17-21-24-27-30-33-36-39-50(59)68-43-47(71-51(60)40-37-34-31-28-25-22-19-16-14-13-15-18-20-23-26-29-32-35-38-46(3)5-2)44-69-74(64,65)73-75(66,67)70-45-48-52(61)53(62)54(72-48)58-42-41-49(56)57-55(58)63/h10-12,17,41-42,46-48,52-54,61-62H,4-9,13-16,18-40,43-45H2,1-3H3,(H,64,65)(H,66,67)(H2,56,57,63)/b11-10-,17-12-/t46?,47-,48-,52+,53?,54-/m1/s1 |
|---|
| InChI Key | FEGACCBCZCMVIV-AMMOKVPISA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as cdp-diacylglycerols. These are glycerolipids containing a diacylglycerol, with a cytidine diphosphate attached to the oxygen O1 or O2 of the glycerol part. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | CDP-glycerols |
|---|
| Direct Parent | CDP-diacylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cdp-diacylglycerol
- Pyrimidine ribonucleoside diphosphate
- Diacyl-glycerol-3-pyrophosphate
- Pentose phosphate
- Pentose-5-phosphate
- Glycosyl compound
- N-glycosyl compound
- Monosaccharide phosphate
- Organic pyrophosphate
- Fatty acid ester
- Monoalkyl phosphate
- Hydroxypyrimidine
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Hydropyrimidine
- Pyrimidine
- Phosphoric acid ester
- Monosaccharide
- Organic phosphoric acid derivative
- Heteroaromatic compound
- Tetrahydrofuran
- Carboxylic acid ester
- 1,2-diol
- Secondary alcohol
- Oxacycle
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Organopnictogen compound
- Organic oxide
- Alcohol
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayDisease pathway- Cardiolipin Biosynthesis CL(a-13:0/18:2(9Z,11Z)/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0043327)
- Cardiolipin Biosynthesis CL(a-13:0/a-13:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0043649)
- Cardiolipin Biosynthesis CL(a-13:0/a-21:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0044616)
- Cardiolipin Biosynthesis CL(a-13:0/i-16:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0046550)
- Cardiolipin Biosynthesis CL(a-13:0/i-18:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0047196)
- Cardiolipin Biosynthesis CL(a-13:0/i-19:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0047518)
- Cardiolipin Biosynthesis CL(a-13:0/i-20:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0047841)
- Cardiolipin Biosynthesis CL(a-13:0/i-24:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0048805)
- Cardiolipin Biosynthesis CL(i-12:0/a-25:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0050742)
- Cardiolipin Biosynthesis CL(i-12:0/i-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0052037)
- Cardiolipin Biosynthesis CL(i-12:0/i-20:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0053652)
- Cardiolipin Biosynthesis CL(i-12:0/i-22:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0054299)
- Cardiolipin Biosynthesis CL(i-13:0/a-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0055591)
- Cardiolipin Biosynthesis CL(i-13:0/i-14:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0057535)
- Cardiolipin Biosynthesis CL(i-13:0/i-16:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0058192)
- Cardiolipin Biosynthesis CL(i-14:0/i-12:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0061652)
- Cardiolipin Biosynthesis CL(a-13:0/a-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0043972)
- Cardiolipin Biosynthesis CL(i-12:0/18:2(9Z,11Z)/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0049128)
- Cardiolipin Biosynthesis CL(i-12:0/a-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0049772)
- Cardiolipin Biosynthesis CL(i-12:0/a-17:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0050096)
- Cardiolipin Biosynthesis CL(i-12:0/i-12:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0051067)
- Cardiolipin Biosynthesis CL(i-12:0/i-18:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0053006)
- Cardiolipin Biosynthesis CL(i-12:0/i-19:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0053329)
- Cardiolipin Biosynthesis CL(i-12:0/i-24:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0054621)
- Cardiolipin Biosynthesis CL(i-13:0/a-13:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0055267)
- Cardiolipin Biosynthesis CL(i-13:0/a-21:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0056239)
- Cardiolipin Biosynthesis CL(i-13:0/i-12:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0056890)
- Cardiolipin Biosynthesis CL(i-13:0/i-18:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0058842)
- Cardiolipin Biosynthesis CL(i-13:0/i-19:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0059183)
- Cardiolipin Biosynthesis CL(i-13:0/i-21:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0059842)
- Cardiolipin Biosynthesis CL(i-13:0/i-24:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0060507)
- Cardiolipin Biosynthesis CL(i-14:0/a-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0061159)
- Cardiolipin Biosynthesis CL(i-14:0/i-14:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0062297)
- Cardiolipin Biosynthesis CL(a-13:0/a-17:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0044294)
- Cardiolipin Biosynthesis CL(a-13:0/a-25:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0044939)
- Cardiolipin Biosynthesis CL(a-13:0/i-12:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0045263)
- Cardiolipin Biosynthesis CL(a-13:0/i-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0046227)
- Cardiolipin Biosynthesis CL(a-13:0/i-21:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0048160)
- Cardiolipin Biosynthesis CL(i-12:0/a-21:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0050419)
- Cardiolipin Biosynthesis CL(i-12:0/i-13:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0051391)
- Cardiolipin Biosynthesis CL(i-12:0/i-16:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0052360)
- Cardiolipin Biosynthesis CL(i-12:0/i-17:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0052683)
- Cardiolipin Biosynthesis CL(i-12:0/i-21:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0053976)
- Cardiolipin Biosynthesis CL(i-13:0/i-20:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0059507)
- Cardiolipin Biosynthesis CL(i-14:0/i-13:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0061974)
- Cardiolipin Biosynthesis CL(i-14:0/i-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0062620)
- Cardiolipin Biosynthesis CL(a-13:0/i-14:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0045903)
- Cardiolipin Biosynthesis CL(a-13:0/i-17:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0046873)
- Cardiolipin Biosynthesis CL(a-13:0/i-22:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0048483)
- Cardiolipin Biosynthesis CL(i-12:0/a-13:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0049451)
- Cardiolipin Biosynthesis CL(i-12:0/i-14:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0051715)
- Cardiolipin Biosynthesis CL(i-13:0/18:2(9Z,11Z)/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0054943)
- Cardiolipin Biosynthesis CL(i-13:0/a-17:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0055913)
- Cardiolipin Biosynthesis CL(i-13:0/a-25:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0056565)
- Cardiolipin Biosynthesis CL(i-13:0/i-15:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0057867)
- Cardiolipin Biosynthesis CL(i-13:0/i-22:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0060177)
- Cardiolipin Biosynthesis CL(i-14:0/a-13:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0060835)
- Cardiolipin Biosynthesis CL(i-14:0/i-16:0/18:2(9Z,11Z)/a-25:0) (PathBank: SMP0062960)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 9.32 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 30.798 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.9 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5759.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 201.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 388.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 192.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1218.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1821.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1463.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 322.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3330.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1370.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2936.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1306.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 777.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 200.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 397.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.6 seconds | 40023050 |
Predicted Kovats Retention IndicesNot Available |
|---|
| MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 10V, Positive-QTOF | splash10-03di-0911000100-d7d19d35ca1525587539 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 20V, Positive-QTOF | splash10-03di-2911000100-2ff2d5bca8ddf5499fd2 | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 40V, Positive-QTOF | splash10-03di-3912000000-043ec2bef26b0cb64c8c | 2019-02-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 10V, Negative-QTOF | splash10-08i0-2973000110-71293a4d25bda952f363 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 20V, Negative-QTOF | splash10-03fr-7794210020-3fb6533b3d3e150296d3 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 40V, Negative-QTOF | splash10-0bvi-5911000000-a02c1a3bd06acbb68e70 | 2019-02-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 10V, Positive-QTOF | splash10-0udi-9400000001-9b2d632030330edf5271 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 20V, Positive-QTOF | splash10-0a59-9000000004-af1e7cac512f22044c7d | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 40V, Positive-QTOF | splash10-00di-0134691000-110e4a30755a94c792a3 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 10V, Negative-QTOF | splash10-0udi-1900000100-d3adc1136108b03ad7b6 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 20V, Negative-QTOF | splash10-01tc-9124800310-503e05be24b2a7b9267d | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - CDP-DG(18:2(9Z,11Z)/a-25:0) 40V, Negative-QTOF | splash10-06si-5409100210-c019ffd4a29aec09b499 | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|